Close X
Wednesday, December 4, 2024
ADVT 
International

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Darpan News Desk IANS, 02 May, 2022 11:25 AM
  • Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

New York, May 2 (IANS) Omicron's latest subvariant BA.2.12.1, responsible for about one-fourth of Covid-19 cases in the US, shows that the virus is not showing any signs of decline even over two years after it was first detected in humans.

BA.2.12.1 has also been detected in Australia and New Zealand.

Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

According to virologists, although the SARS-CoV-2 virus has repeatedly changed its structure and chemistry, it still has abundant evolutionary space to explore, Washington Post reported.

While existing vaccination can still reduce the risk of severe Covid disease, the variants can evade many of the neutralising antibodies that are the immune system's front line of defence.

"It's evolving at a fairly rapid rate. I do think we need to aggressively consider whether we should update vaccines, and do it soon," Jesse Bloom, a computational biologist at the Fred Hutchinson Cancer Research Center in Seattle was quoted as saying.

"The evolution is much more rapid and expansive than we initially estimated," added Michael Osterholm, infectious-disease expert at the University of Minnesota.

"Every day I wake up, I fear there will be a new subvariant that we will have to consider. . . We're seeing sub-variants of sub-variants," he added.

Other mutations include BA.4 and BA.5, recently identified by scientists in South Africa. It has led to a fresh wave of Covid in the country.

Besides South Africa, the sub variants have also been detected in more than 20 countries including Australia, Austria, Belgium, China, Israel, Denmark, France, Germany, Pakistan, UK, US and Switzerland.

Apart from mutation, the virus has another trick up its sleeve: recombination. It happens when two distinct strains infect a single host simultaneously and their genes become entangled, the Post reported.

The recombination process is the origin of what's known as Omicron XE. That recombinant probably emerged from a person co-infected with the original Omicron variant and the BA.2 subvariant.

It was always possible in theory, but the identification of actual recombinants provides "proof of concept," Jeremy Luban, a virologist at the University of Massachusetts Medical School was quoted as saying.

The worst-case scenario would be the emergence of a variant or recombinant that renders current vaccines largely ineffective at blocking severe disease. But so far, that hasn't happened. And no "recombinant" has spread like Omicron or other recent variants and sub-variants, the report said.

MORE International ARTICLES

White House on U.S. vaccine supply: America first

White House on U.S. vaccine supply: America first
That's despite the challenges faced by other countries, including Canada, in procuring vaccine doses from outside the United States.

White House on U.S. vaccine supply: America first

Attacks on older Asians stoke fear as Lunar New Year begins

Attacks on older Asians stoke fear as Lunar New Year begins
City officials also have visited Chinatowns in San Francisco and Oakland this week to address residents' safety concerns and condemn the violence.

Attacks on older Asians stoke fear as Lunar New Year begins

UN: 'Concerning news' vaccines may not work against variants

UN: 'Concerning news' vaccines may not work against variants
Tedros added that WHO expected to make a decision “in the next few days” on whether it would recommend an emergency use listing for the AstraZeneca vaccine.

UN: 'Concerning news' vaccines may not work against variants

Britain to test mixing and matching of COVID-19 vaccines

Britain to test mixing and matching of COVID-19 vaccines
The vaccines being rolled out now require two doses, and people are supposed to get two shots of the same kind, weeks apart.

Britain to test mixing and matching of COVID-19 vaccines

In U.S., Europe, hope about future health crises

In U.S., Europe, hope about future health crises
The Pew Research Center poll out today finds optimism for the future among a majority of 4,000 respondents in the U.S., the United Kingdom, France and Germany.

In U.S., Europe, hope about future health crises

Don't sell single-shot vaccine short, Fauci says

Don't sell single-shot vaccine short, Fauci says
Dr. Anthony Fauci says Johnson and Johnson's vaccine has virtues beyond an efficacy rate that lags that of its predecessors.

Don't sell single-shot vaccine short, Fauci says